glp 1 agonists anesthesia Glucagon-Like Peptide Receptor and Aspiration Risk One-Week GLP-1 Agonist Hold Not

Public reimbursement accounts for only 15% of the market, primarily covering patients with severe obesity and documented metabolic complications

10.1371/journal.pone.0012226 30

These knowledge gaps pose barriers to translation and have contributed to the absence of clinical guidance for their use in this setting

Gastric acidity, reflux, and other gastrointestinal symptoms Three articles indicated that there was also no significant difference in reflux symptoms experienced by patients taking GLP-1 RAs versus those who were not (Santos et al

Metformin has been widely studied for its ability to improve insulin sensitivity and support overall metabolic health

According to the World Health Organization (WHO), it is estimated that around 77 million adults are presently living with type 2 diabetes and nearly 25 million are classified as prediabetic